1. Roles of BMI1 in the Initiation, Progression, and Treatment of Hepatocellular Carcinoma
   Ru Wang et al, 2022, Technology in Cancer Research & Treatment CrossRef
2. PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis
   Giulia Elda Valenti et al, 2023, Antioxidants CrossRef
3. Lymphangiogenesis and Stem Cells in Hematological Malignancies
   Isabel Vidal et al, 2024, Comprehensive Hematology and Stem Cell Research CrossRef
4. Non-coding RNAs regulating epithelial-mesenchymal transition: Research progress in liver disease
   Xiang Yang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
5. Natural bioactive compounds and STAT3 against hepatocellular carcinoma: An update
   Suryaa Manoharan et al, 2024, Life Sciences CrossRef
6. B-cell specific Moloney murine leukemia virus insertion site 1 contributes to invasion, metastasis, and poor prognosis in salivary adenoid cystic carcinoma
   Rongyan Wang et al, 2024, Journal of Dental Sciences CrossRef
7. BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer
   Janaki Ramaiah M. et al, 2018, Gene CrossRef
8. Update on the role and therapeutic potential of polycomb repressive complexes in (biliary tract) cancer
   Daniel Neureiter et al, 2018, Expert Opinion on Therapeutic Targets CrossRef
9. ALDH1 expression correlates with an epithelial-like phenotype and favorable prognosis in lung adenocarcinoma: a study based on immunohistochemistry and mRNA expression data
   Young Wha Koh et al, 2019, Journal of Cancer Research and Clinical Oncology CrossRef
10. Systems biology investigation of epithelial-mesenchymal transition in hepatocellular carcinoma pathogenesis
    Fatemeh karimpour et al, 2023, Informatics in Medicine Unlocked CrossRef